BIOTRANSPLANT AND METHOD FOR TREATING THE CASES OF DIABETES MELLITUS OF TYPE I AND II

FIELD: medicine; medical engineering. ^ SUBSTANCE: biotransplant has genetically unmodified mesenchyma stem cell culture as active component obtained from fetal donor autologous material and genetically unmodified fetal myoblast culture. Method involves intravenously dropping mesenchyma stem cells i...

Full description

Saved in:
Bibliographic Details
Main Authors REPIN V.S, UTJASHEV I.A, MAKAROV A.V, RZHANINOVA A.A, FATKHUDINOV T.KH, GOL'DSHTEJN D.V, PULIN A.A, SABURINA I.N, SHAMENKOV D.A, BAZHANOV N.A
Format Patent
LanguageEnglish
Russian
Published 10.12.2005
Edition7
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:FIELD: medicine; medical engineering. ^ SUBSTANCE: biotransplant has genetically unmodified mesenchyma stem cell culture as active component obtained from fetal donor autologous material and genetically unmodified fetal myoblast culture. Method involves intravenously dropping mesenchyma stem cells in the amount of 50 to 500 mln in 50-100 ml of physiologic saline. The fetal myoblast culture is intramuscularly introduced at a dose of 100 mln of cells per 10 kg. ^ EFFECT: enhanced effectiveness in repairing incretory function of pancreas and reducing resistance to insulin; reduced risk of nephropathy and other complications. ^ 9 cl
Bibliography:Application Number: RU20040114505